Aratana Therapeutics, a pet therapeutics company focused on the licensing, development and commercialization of innovative biopharmaceutical products for companion animals, won Animal Pharm’s Best Company in North America 2016.
Aratana was granted the award based on the FDA approval of three innovative therapeutics in 2016, GALLIPRANT® (grapiprant tablets), ENTYCE® (capromorelin oral solution) and NOCITA® (bupivacaine liposome injectable suspension), as well as the Company’s evolution to a fully integrated commercial company. This is the third consecutive year Aratana has been honored with an award from Animal Pharm.
